T. S. Elizan

605 total citations
19 papers, 414 citations indexed

About

T. S. Elizan is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, T. S. Elizan has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in T. S. Elizan's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Herpesvirus Infections and Treatments (5 papers) and Neurological disorders and treatments (4 papers). T. S. Elizan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Herpesvirus Infections and Treatments (5 papers) and Neurological disorders and treatments (4 papers). T. S. Elizan collaborates with scholars based in United States and Canada. T. S. Elizan's co-authors include Melvin D. Yahr, J. Casals, G. J. Siegel, A. Fabiyi, J Schwartz, John L. Sever, James G. Wetmur, Chris C. Plato, Donald Lloyd-Smith and Dwayne Reed and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

T. S. Elizan

19 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. S. Elizan United States 11 259 138 67 50 47 19 414
Hermann Hager Germany 12 58 0.2× 124 0.9× 136 2.0× 120 2.4× 20 0.4× 16 417
M. M. Selim Kuwait 7 220 0.8× 56 0.4× 36 0.5× 28 0.6× 6 0.1× 12 404
Fabrine Sales Massafera Tristão Brazil 11 90 0.3× 61 0.4× 55 0.8× 73 1.5× 80 1.7× 19 390
Katherine W. Snapinn United States 7 131 0.5× 49 0.4× 91 1.4× 57 1.1× 55 1.2× 8 305
Toshiki Himeda Japan 13 62 0.2× 103 0.7× 69 1.0× 217 4.3× 94 2.0× 40 519
Yu Kono Japan 10 158 0.6× 53 0.4× 29 0.4× 45 0.9× 10 0.2× 32 368
Michael Podell United States 12 29 0.1× 140 1.0× 43 0.6× 63 1.3× 24 0.5× 16 453
Cristian Setz Switzerland 9 114 0.4× 31 0.2× 93 1.4× 111 2.2× 63 1.3× 19 389
Mihee Jang South Korea 12 244 0.9× 101 0.7× 69 1.0× 95 1.9× 6 0.1× 23 445
Israt Jahan Bangladesh 13 331 1.3× 120 0.9× 40 0.6× 72 1.4× 53 1.1× 51 561

Countries citing papers authored by T. S. Elizan

Since Specialization
Citations

This map shows the geographic impact of T. S. Elizan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. S. Elizan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. S. Elizan more than expected).

Fields of papers citing papers by T. S. Elizan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. S. Elizan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. S. Elizan. The network helps show where T. S. Elizan may publish in the future.

Co-authorship network of co-authors of T. S. Elizan

This figure shows the co-authorship network connecting the top 25 collaborators of T. S. Elizan. A scholar is included among the top collaborators of T. S. Elizan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. S. Elizan. T. S. Elizan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Casals, J., T. S. Elizan, & Melvin D. Yahr. (1998). Postencephalitic parkinsonism – a review. Journal of Neural Transmission. 105(6-7). 645–676. 74 indexed citations
2.
Elizan, T. S.. (1991). Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Disease. Archives of Neurology. 48(1). 31–31. 19 indexed citations
3.
Yahr, Melvin D., et al.. (1989). Selegiline in the treatment of Parkinson's disease - long term experience. Acta Neurologica Scandinavica. 80. 157–161. 15 indexed citations
4.
Madden, David L., Francis K. Mundon, Nancy Tzan, et al.. (1988). Antibody to human and simian retrovirus, HTLV-I, HTLV-II, HIV, STLV-III, and SRV-I not increased in patients with multiple sclerosis. Annals of Neurology. 23(S1). S171–S173. 9 indexed citations
5.
Madden, David L., et al.. (1988). Serologic studies of MS patients, controls, and patients with other neurologic diseases. Neurology. 38(1). 81–81. 10 indexed citations
6.
Elizan, T. S. & J. Casals. (1983). The viral hypothesis in parkinsonism.. PubMed. 19. 75–88. 12 indexed citations
7.
Winkler, M., George J. Dawson, T. S. Elizan, & S. Berl. (1982). Distribution of actin and myosin in a rat neuronal cell line infected with herpes simplex virus. Archives of Virology. 72(1-2). 95–103. 7 indexed citations
8.
Wetmur, James G., J Schwartz, & T. S. Elizan. (1979). Nucleic Acid Homology Studies of Viral Nucleic Acids in Idiopathic Parkinson's Disease. Archives of Neurology. 36(8). 462–464. 26 indexed citations
9.
Elizan, T. S., D. L. Madden, Jason D. Gardner, et al.. (1979). Viral Antibodies in Serum and CSF of Parkinsonian Patients and Controls. Archives of Neurology. 36(9). 529–534. 31 indexed citations
10.
Schwartz, J, et al.. (1978). MYELIN DEGENERATION IN ORGANOTYPIC MOUSE CORD-GANGLION CULTURES INFECTED WITH HERPES SIMPLEX VIRUS (HSV) TYPE 1 AND 2. Journal of Neuropathology & Experimental Neurology. 37(5). 610–610. 1 indexed citations
11.
Elizan, T. S., A. Fabiyi, & H. F. Clark. (1972). Suckling Mouse Cataract Agent (SMCA)-Induced Hydrocephalus and Chronic Brain Infection in Newborn Rats. Experimental Biology and Medicine. 139(1). 51–55. 14 indexed citations
12.
Elizan, T. S., et al.. (1971). Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism. Journal of Neurology Neurosurgery & Psychiatry. 34(6). 668–673. 81 indexed citations
13.
Elizan, T. S., et al.. (1971). Syndrome of acute idiopathic ophthalmoplegia with ataxia and areflexia. Neurology. 21(3). 281–281. 42 indexed citations
14.
Fabiyi, A., et al.. (1971). Suckling Mouse Cataract Agent (SMCA) in Tissue Culture. Experimental Biology and Medicine. 136(1). 88–91. 8 indexed citations
15.
Elizan, T. S., et al.. (1970). A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.. PubMed. 36(6). 503–15. 3 indexed citations
16.
Elizan, T. S., et al.. (1969). Viral Infection in Pregnancy and Congenital CNS Malformations in Man. Archives of Neurology. 20(2). 115–119. 22 indexed citations
17.
Plato, Chris C., Dwayne Reed, T. S. Elizan, & L. T. Kurland. (1967). Amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam. IV. Familial and genetic investigations.. PubMed. 19(5). 617–32. 32 indexed citations
18.
Elizan, T. S., et al.. (1962). The non-surgical management of brain tumor.. PubMed. 87. 20–4. 7 indexed citations
19.
Elizan, T. S., et al.. (1961). Relation of tactile and kinesthetic (proprioceptive) sensibilities.. PubMed. 86. 194–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026